| Literature DB >> 31744663 |
Abstract
To replicate, the human papillomaviruses (HPVs) that cause anogenital and oropharyngeal malignancies must simultaneously activate DNA repair pathways and avoid the cell cycle arrest that normally accompanies DNA repair. For years it seemed that HPV oncogenes activated the homologous recombination pathway to facilitate the HPV lifecycle. However, recent developments show that, although homologous recombination gene expression and markers of pathway activation are increased, homologous recombination itself is attenuated. This review provides an overview of the diverse ways that HPV oncogenes manipulate homologous recombination and ideas on how the resulting dysregulation and inhibition offer opportunities for improved therapies and biomarkers.Entities:
Keywords: DNA repair; cervical cancer; head and neck cancer; homologous recombination; human papillomavirus
Mesh:
Year: 2019 PMID: 31744663 DOI: 10.1016/j.tim.2019.10.008
Source DB: PubMed Journal: Trends Microbiol ISSN: 0966-842X Impact factor: 17.079